| INTERACT is a partnership of Rwandan, Ugandan and European researchers and institutions. It was established from 2005 to 2011 and is funded by both a NACCAP, as well as a Europaid grant. The acronym INTERACT refers to the interaction of the three infections malaria, tuberculosis (TB) and HIV, and to the interactions between the treatments directed against these infections. It also reflects the interaction between research and capacity building: learning by doing. Furthermore it refers to the interaction of highly technical laboratory investigations and clinical trials with implementation in the real world of peripheral clinics. Finally, it refers to the interaction between African scientists, and between African and European scientists in this partnership. Objectives The INTERACT program s overall objective is to contribute to sustainable capacity in Rwanda and Uganda to generate an evidence base for public health policies on HIV/AIDS, tuberculosis and malaria To strength capacity to conduct clinical trials of new drugs, prevention technologies, and interventions for HIV/AIDS, tuberculosis, and malaria, in accordance with international strategies, |
